» Articles » PMID: 27306105

Impact of Environmental and Familial Factors in a Cohort of Pediatric Patients With Inflammatory Bowel Disease

Overview
Publisher Wiley
Date 2016 Jun 17
PMID 27306105
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The primary role of environment on inflammatory bowel disease (IBD) onset has been recently stressed. We aimed to investigate the effect of environmental factors in an IBD pediatric cohort.

Methods: A total of 467 subjects (264 IBD and 203 controls) were enrolled. All patients underwent a questionnaire including 5 different groups of environmental risk factors: family history of IBD and autoimmune diseases, perinatal period, home amenities and domestic hygiene, childhood diseases and vaccinations, and diet.

Results: In a multivariate model, mother's degree (odds ratio [OR]: 5.5; 2.5-11.6), duration of breast feeding >3rd month (OR: 4.3; 1.6-10.5), father's employment (OR: 3.7; 1.2-8.7), gluten introduction <6th month (OR: 2.8; 1.5-5), number of siblings <2 (OR: 2.8; 1.5-5.3), and family history of autoimmune diseases (OR: 2.7; 1.4-5.3) were significant risk factors for Crohn disease. Low adherence to Mediterranean diet (OR: 2.3; 1.2-4.5), gluten introduction <6th month (OR: 2.8; 1.6-4.9), and number of siblings <2 (OR: 2; 1.1-3.6) were significant risk factors for ulcerative colitis. Owning pets (OR: 0.3; 0.1-0.7) and bed sharing (OR: 0.2; 0.1-0.6) were protective factors for Crohn disease, whereas owning pets (OR: 0.4; 0.2-0.8) and family parasitosis (OR: 0.07; 0.01-0.4) were protective factors for ulcerative colitis.

Conclusions: Our study confirms that environmental factors are closely linked to IBD onset and may partly explain IBD rise in developed countries.

Citing Articles

Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases.

Calvez V, Puca P, Di Vincenzo F, Del Gaudio A, Bartocci B, Murgiano M Biomedicines. 2025; 13(2).

PMID: 40002718 PMC: 11853239. DOI: 10.3390/biomedicines13020305.


Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches.

Centanni L, Cicerone C, Fanizzi F, DAmico F, Furfaro F, Zilli A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861141 PMC: 11768140. DOI: 10.3390/ph18010078.


Dietary content and eating behavior in ulcerative colitis: a narrative review and future perspective.

Qin L, Lv W Nutr J. 2025; 24(1):12.

PMID: 39849464 PMC: 11755847. DOI: 10.1186/s12937-025-01075-y.


The Role of Maternal and Early-Life Diet in Inflammatory Bowel Disease.

Karaivazoglou K, Triantos C, Aggeletopoulou I Nutrients. 2025; 16(24.

PMID: 39770913 PMC: 11677091. DOI: 10.3390/nu16244292.


Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers.

Mestrovic A, Perkovic N, Bozic D, Kumric M, Vilovic M, Bozic J Biomedicines. 2024; 12(7).

PMID: 39062093 PMC: 11274502. DOI: 10.3390/biomedicines12071520.